Watertown Local Business
Local business in Watertown, MA
Tuesday Dec 23 | via Information Technology
Selecta Biosciences , a clinical-stage biotechnology company developing novel drugs that use immune-modulating nanomedicines based on Synthetic Vaccine Particles , announced today that it has been awarded a $3.2 million grant from Skolkovo Foundation in support of Selecta's program to develop an SVP immunotherapy to treat cancers caused by infections with Human Papilloma Virus , such as cervical, head and neck cancers. The grant award will assist with advancing an SVP cancer immunotherapy from preclinical through early clinical evaluation. Comment?
Thursday Dec 18 | via Pharmaceutical Processing
Shares of Tetraphase Pharmaceuticals soared Thursday morning, a day after the drug developer said its potential infection fighter eravacycline fared well compared to another treatment in late-stage clinical testing. The Watertown, Massachusetts, company said eravacycline proved to be not inferior to a competing drug, ertapenem, and patients taking it had no serious, drug-related side effects, according to early results from the study. Comment?
Monday Dec 15 | via BroadwayWorld.com
The Collective NY is launching VOL.2 of The COLLECTIVE:10 ANTHOLOGY today, December 16 at the Drama Book Shop. The anthology contains the 12 original short plays that premiered as part of the 2nd annual Collective:10 this past October. Comment?
Thursday Dec 11 | via Business Wire
Led by Rani George, MD, PhD of the Dana-Farber Cancer Institute, along with Syros Scientific Co-Founders Richard Young, PhD and Nathanael Gray, PhD, the paper entitled "CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer,"1 was published in Cell on November 20, 2014. In the study, the researchers found that a covalent inhibitor of CDK7 caused substantial suppression of MYCN-driven transcriptional amplification and produced sustained tumor growth inhibition in a mouse model of MYCN amplified neuroblastoma, a cancer of children. Comment?
Wednesday Dec 10 | via PR-inside.com
It offers foam system product for acute hemorrhage. Arsenal's foam system is an in-situ foaming foams, which is designed for the control of severe, intra-cavity hemorrhage. Comment?
Copyright © 2014 Topix LLC